RxDoctor Payments Data

Arnold Peterson, MD

Internal Medicine · Trumbull, CTNPI 1881868867

Payments from drug & device makers

$711in general payments, 2019–2025

Across 49 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$678
  • AbbVie$19
  • Amgen$14

What the payments were for

  • Food & beverage$69798%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk47$678
AbbVie1$19
Amgen1$14

How this compares

$711 in reported general payments places this provider in the 70th percentile of 2,067 internal medicine providers in Connecticut.

See all internal medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$134,851
Medicare patients
311
Services billed
1,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$122,328
JardianceEmpagliflozin72$112,502
MounjaroTirzepatide33$45,118
EliquisApixaban46$35,920
RybelsusSemaglutide12$34,237
JanuviaSitagliptin Phosphate17$27,840
Janumet XrSitagliptin Phos/Metformin Hcl18$20,256
MyrbetriqMirabegron16$16,087
LinzessLinaclotide15$8,382
NexletolBempedoic Acid14$5,254
SymbicortBudesonide/Formoterol Fumarate17$4,493
Breo ElliptaFluticasone/Vilanterol11$4,468
Metoprolol Succinate220$3,426
Rosuvastatin Calcium282$3,304
Pravastatin Sodium245$2,946

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$678$156,56593 claims
AbbVieLinzess, Synthroid$19$11,02349 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,067 internal medicine providers in Connecticut.

Other internal medicine in Trumbull

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →